Hopp til innhold
Historical Archives: This content is archived and will not be updated.

Get alerts of updates about «Operating room ventilation»

How often would you like to receive alerts from fhi.no? (This affects all your alerts)
Do you also want alerts about:

The email address you register will only be used to send you these alerts. You can cancel your alerts and delete your email address at any time by following the link in the alerts you receive.
Read more about the privacy policy for fhi.no

You have subscribed to alerts about:

  • Operating room ventilation

Health technology assessment

Operating room ventilation: a health technology assessment

Published

We conducted a health technology assessment to eval-uate the efficacy of laminar airflow (LAF) in reducing surgical site infections.

Forside Ventilasjon op-stuer.jpg

We conducted a health technology assessment to eval-uate the efficacy of laminar airflow (LAF) in reducing surgical site infections.


Downloadable as PDF. In Norwegian. English key messages.

About this publication

  • Year: 2022
  • By: Norwegian Institute of Public Health
  • Authors Risstad H, Evensen LH, Movik E, Lerner M.
  • ISBN (digital): 978-82-8406-277-8

Key message

This edition has been replaced by a new version published on 3rd May 2022; Operating room ventilation - revised edition

Surgical site infections are associated with increased morbidity and mortality. The role of the operating theatre ventilation system in preventing surgical site infections has been discussed for decades.

We conducted a health technology assessment to evaluate the efficacy of laminar airflow (LAF) in reducing surgical site infections. We included 22 observational studies. All studies were at moderate or serious risk of bias.  The effect estimates were imprecise, and there were somewhat lack of consistency of the results across the included studies. For the comparison of LAF with conventional ventilation, we found that:   

  • There were no difference in rates of serious surgical site infections (SSI) in all types of surgery and in joint prosthesis surgery (GRADE: low certainty)
  • There were no difference in rates of all SSIs in all types of surgery and in joint prosthesis surgery (GRADE: very low certainty)
  • We found no studies that provide sufficient information on the effect on mortality
  • We estimated the additional annual costs for one opeating theathre with LAF to be NOK 41 000 discounted over a 30-day period and 77 000 discounted over a 10-year period. The estimate is associated with uncertainty.